Suppr超能文献

第二届登革热终结峰会会议记录:行动呼吁

Proceedings of the second annual dengue endgame summit: A call to action.

作者信息

Hardy Céline S C, Bahr Lauren E, Rothman Alan L, Anderson Kathryn B, Barba-Spaeth Giovanna, Weiskopf Daniela, Ooi Eng Eong, Marques Ernesto T A, Bonsignori Mattia, Barrett Alan D T, Kirkpatrick Beth D, Castanha Priscila M S, Hamins-Puertolas Marco, Christofferson Rebecca C, Dimopoulos George, Oliveira Fabiano, Chiang Lillian W, Ko Albert I, Gunale Bhagwat, Kulkarni Prasad, Perkins T Alex, Dorigatti Ilaria, Stewart Telisa, Shaw Jana, Johansson Michael A, Thomas Stephen J, Waickman Adam T

机构信息

Department of Microbiology and Immunology, Upstate Medical University, Syracuse, New York, United States of America.

Department of Cell and Molecular Biology, Institute for Immunology and Informatics, University of Rhode Island, Kingston, Rhode Island, United States of America.

出版信息

PLoS Negl Trop Dis. 2025 Apr 28;19(4):e0013028. doi: 10.1371/journal.pntd.0013028. eCollection 2025 Apr.

Abstract

On August 7-9, 2024, the second annual dengue "endgame" summit was held in Syracuse, NY, hosted by the Global Health Institute at SUNY Upstate Medical University. The meeting brought together attendees from around the world, with talks spanning healthcare, government control programs, basic research, and medical countermeasure development efforts. The summit goal was to work toward a better understanding of what dengue control could look like and the steps required to reach such a goal. The objectives of the meeting were to discuss the current global state of dengue, what dengue "control" might look like, and to discuss actionable pathways for achieving dengue control. Topics covered throughout the meeting included DENV immunity and pathogenesis, challenges in countermeasure development, innovative vector control strategies, dengue diagnostics, addressing challenges in science communication, and vaccine hesitancy. Several fundamental knowledge gaps were repeatedly highlighted by the summit attendees and were cited as critical barriers to the development, deployment, and evaluation of effective dengue countermeasures. These gaps include (1) the lack of a broadly applicable immunologic biomarker/correlate of DENV immunity and (2) the lack of universally accepted/applicable metrics for quantifying dengue severity in the setting of countermeasure evaluations. In addition, the lack of clear and consistent international leadership in the global dengue control effort was cited as a barrier to widespread and synergistic research and countermeasure development/deployment activities. Despite these persistent roadblocks, summit attendees expressed optimism that holistic and multi-tiered approaches-incorporating optimal use of existing and nascent countermeasure technologies deployed in collaboration with local communities-could be effective in progressing toward dengue control.

摘要

2024年8月7日至9日,第二届年度登革热“终结”峰会在纽约州锡拉丘兹举行,由纽约州立大学上州医科大学全球健康研究所主办。会议汇聚了来自世界各地的与会者,讨论内容涵盖医疗保健、政府防控项目、基础研究以及医学对策开发工作。峰会的目标是努力更好地理解登革热防控可能的样子以及实现这一目标所需的步骤。会议的目的是讨论登革热的当前全球状况、登革热“防控”可能是什么样,并讨论实现登革热防控的可行途径。会议涵盖的主题包括登革病毒免疫和发病机制、对策开发中的挑战、创新的病媒控制策略、登革热诊断、应对科学传播中的挑战以及疫苗犹豫问题。峰会与会者多次强调了几个基本的知识空白,并将其视为有效登革热对策开发、部署和评估的关键障碍。这些空白包括:(1)缺乏广泛适用的免疫生物标志物/登革病毒免疫相关指标;(2)在对策评估中缺乏普遍接受/适用的量化登革热严重程度的指标。此外,全球登革热防控努力缺乏明确和一致的国际领导被认为是广泛和协同的研究以及对策开发/部署活动的障碍。尽管存在这些持续的障碍,峰会与会者表示乐观地认为,结合与当地社区合作最佳利用现有和新兴对策技术的整体和多层次方法,可能有效地推动登革热防控工作取得进展。

相似文献

1
Proceedings of the second annual dengue endgame summit: A call to action.
PLoS Negl Trop Dis. 2025 Apr 28;19(4):e0013028. doi: 10.1371/journal.pntd.0013028. eCollection 2025 Apr.
2
Proceedings of the dengue endgame summit: Imagining a world with dengue control.
Vaccine. 2024 Oct 3;42(23):126071. doi: 10.1016/j.vaccine.2024.06.038. Epub 2024 Jun 17.
3
Dengue: knowledge gaps, unmet needs, and research priorities.
Lancet Infect Dis. 2017 Mar;17(3):e88-e100. doi: 10.1016/S1473-3099(16)30473-X. Epub 2017 Feb 7.
4
Call to action for dengue vaccine failure.
Emerg Infect Dis. 2013 Aug;19(8):1335-7. doi: 10.3201/eid1908.121864.
5
Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine.
J Virol. 2014 Sep;88(18):10813-30. doi: 10.1128/JVI.00810-14. Epub 2014 Jul 9.
6
Dengue mouse models for evaluating pathogenesis and countermeasures.
Curr Opin Virol. 2020 Aug;43:50-58. doi: 10.1016/j.coviro.2020.09.001. Epub 2020 Sep 17.
7
Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control.
Cell. 2015 Jul 30;162(3):488-92. doi: 10.1016/j.cell.2015.07.005.
8
Anti-dengue Vaccines: From Development to Clinical Trials.
Front Immunol. 2020 Jun 18;11:1252. doi: 10.3389/fimmu.2020.01252. eCollection 2020.
9
Prospects for a dengue virus vaccine.
Nat Rev Microbiol. 2007 Jul;5(7):518-28. doi: 10.1038/nrmicro1690.
10
Dengue research opportunities in the Americas.
J Infect Dis. 2012 Oct 1;206(7):1121-7. doi: 10.1093/infdis/jis351. Epub 2012 Jul 9.

本文引用的文献

1
B cell receptor dependent enhancement of dengue virus infection.
PLoS Pathog. 2024 Oct 31;20(10):e1012683. doi: 10.1371/journal.ppat.1012683. eCollection 2024 Oct.
3
Proceedings of the dengue endgame summit: Imagining a world with dengue control.
Vaccine. 2024 Oct 3;42(23):126071. doi: 10.1016/j.vaccine.2024.06.038. Epub 2024 Jun 17.
4
mRNA-encoded Cas13 can be used to treat dengue infections in mice.
Nat Microbiol. 2024 Aug;9(8):2160-2172. doi: 10.1038/s41564-024-01726-6. Epub 2024 Jun 5.
6
Antibodies to D7L salivary proteins as a new serological tool to estimate human exposure to mosquitoes.
Front Immunol. 2024 May 1;15:1368066. doi: 10.3389/fimmu.2024.1368066. eCollection 2024.
7
Identification and characterization of a nonbiological small-molecular mimic of a Zika virus conformational neutralizing epitope.
Proc Natl Acad Sci U S A. 2024 May 21;121(21):e2312755121. doi: 10.1073/pnas.2312755121. Epub 2024 May 14.
10
Low-dose dengue virus 3 human challenge model: a phase 1 open-label study.
Nat Microbiol. 2024 May;9(5):1356-1367. doi: 10.1038/s41564-024-01668-z. Epub 2024 Apr 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验